Can a Death Doula Support Someone with Bronchial Carcinoid or Lung Neuroendocrine Tumor?
By CRYSTAL BAI •
The short answer: Yes. A death doula can support someone with advanced bronchial carcinoid or lung neuroendocrine tumor by navigating the unique trajectory of pulmonary NETs — often slower than other lung cancers — and providing compassionate family support when disease progresses despite long management.
Can a Death Doula Support Someone with Bronchial Carcinoid or Lung Neuroendocrine Tumor?
Bronchial carcinoids are low-grade neuroendocrine tumors of the lung. Typical carcinoids have an excellent prognosis; atypical carcinoids have intermediate prognosis; and large cell neuroendocrine carcinoma (LCNEC) is highly aggressive. For patients with advanced or metastatic bronchial carcinoid that progresses through multiple treatments, a death doula provides essential end-of-life support.
Pulmonary NET Disease Trajectory
Typical bronchial carcinoids are often cured with surgery. Atypical carcinoids with metastases may be managed for years with somatostatin analogs, PRRT, and systemic therapies. LCNEC is aggressive and treated similarly to small cell lung cancer. A death doula helps patients and families navigate the appropriate trajectory for their specific tumor type.
Carcinoid Syndrome
Some bronchial carcinoids secrete serotonin and other hormones causing carcinoid syndrome — flushing, diarrhea, wheezing, and in some cases carcinoid heart disease. Managing these symptoms is central to quality of life. A death doula helps patients and families understand and communicate their symptom burden to the medical team.
How Renidy Supports Bronchial Carcinoid Families
Renidy connects bronchial carcinoid patients and families with death doulas experienced in neuroendocrine tumors and pulmonary malignancies, who can provide support through both the extended management phase and ultimately through end-of-life care.
Frequently Asked Questions
What is the prognosis for bronchial carcinoid?
Typical carcinoids have a 5-year survival of >90% with surgical resection. Atypical carcinoids have a more variable prognosis, with 5-year survival of 60–80% for localized disease, lower for metastatic disease. LCNEC has a poor prognosis similar to small cell lung cancer.
Is carcinoid tumor the same as carcinoid syndrome?
No. Carcinoid tumor (now called neuroendocrine tumor) refers to the cancer itself. Carcinoid syndrome is a set of symptoms — flushing, diarrhea, wheezing — caused by hormones secreted by certain carcinoid tumors, particularly when they metastasize to the liver or arise in the bronchus.
Are there support resources for carcinoid/NET patients?
The Carcinoid Cancer Foundation (carcinoid.org) and Neuroendocrine Tumor Research Foundation (netrf.org) provide patient education, support resources, and clinical trial information. Renidy's death doulas provide complementary one-on-one support.
When should bronchial carcinoid patients think about end-of-life planning?
End-of-life planning is appropriate for any patient with metastatic carcinoid, particularly those with atypical carcinoids, carcinoid heart disease, or LCNEC. Advance directives and goals-of-care conversations should be completed while the person has full capacity for decision-making.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.